Related Experiment Video
Updated: Jun 3, 2026
05:26
Fabrication of Size-Controlled and Emulsion-Free Chitosan-Genipin Microgels for Tissue Engineering Applications
Published on: April 13, 2022
Chitosan nanoparticles as a dual growth factor delivery system for tissue engineering applications
Merlin Rajam1, S Pulavendran, Chellan Rose
1Department of Biotechnology, Central Leather Research Institute (Council of Scientific and Industrial Research), Adyar, Chennai 20, Tamil Nadu, India.
International Journal of Pharmaceutics
|March 12, 2011
Summary
Chitosan nanoparticles (CNP) effectively deliver growth factors like epidermal growth factor (EGF) and fibroblast growth factor (FGF) for cellular signaling. These nanoparticles show sustained release, no toxicity, and promote fibroblast proliferation, aiding regenerative medicine applications.
Area of Science:
- Biomaterials Science
- Regenerative Medicine
- Nanotechnology
Background:
- Growth factors are crucial for cellular processes like migration and proliferation.
- Sustainable delivery of therapeutic proteins is vital for pharmacological and regenerative medicine.
- Chitosan nanoparticles (CNP) offer a promising platform for controlled protein release.
Purpose of the Study:
- To prepare and characterize chitosan nanoparticles (CNP) for growth factor delivery.
- To evaluate the sustained release, biocompatibility, and efficacy of EGF and FGF loaded CNP.
- To assess the potential of CNP-based growth factor delivery in engineered tissue constructs.
Main Methods:
- Chitosan nanoparticles (CNP) were synthesized and characterized using FTIR, Zeta sizer, and HRTEM.
- Epidermal growth factor (EGF) and fibroblast growth factor (FGF) were incorporated into CNP.
- In vitro release kinetics, cytotoxicity assays against fibroblasts, and proliferation assays were performed.
- Western blotting was used to analyze inflammatory cytokine expression (IL-6, TNFα) in macrophage cell lines.
Main Results:
- CNP were characterized as round, flat particles in the size range of 50-100 nm.
- Sustained release of both EGF and FGF from CNP was observed.
- CNP loaded with growth factors exhibited no toxicity to fibroblasts up to 4 mg/ml.
- Significant increase in fibroblast proliferation and reduced inflammatory cytokine expression (IL-6, TNFα) were noted.
Conclusions:
- Chitosan nanoparticles provide a viable system for sustained delivery of EGF and FGF.
- The developed CNP are biocompatible and promote cellular signaling for tissue regeneration.
- This approach holds potential for applications in regenerative medicine and tissue engineering.
